More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side effects.

The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and deaths.

Medicine Ozempic without the side effects? New drug touted as weight loss game changer By Diana Bruk Published June 26, 2025, 5:36 p.m. ET ...

He’s also very sensitive about his weight. Is it wrong for me to try to get him to take Ozempic? I’m hoping that losing weight will help boost his energy levels, which might lead to more self ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves once each week. In newly released clinical trial data, Amgen’s once ...

Patients taking semaglutide, the active ingredient in Ozempic, were less likely to develop Alzheimer’s. Randomized clinical trials are needed to pin down the exact cause of this difference in risk.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users.